Nexxir SRL
Nexxir reported total assets of 172,635 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Nexxir shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nexxir's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
Nexxir's financial analysis
- Solvency73.2%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nexxir
Nexxir's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1008.091.207
- VAT number
- BE1008091207
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 05 Apr 2024
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Nexxir (SRL) has been based in Jette since 2024, active in: general medical practice activities. For 2025, it reports a net profit of 79,001 € and equity of 126,440 €; its revenue is not published. Its solvency stands at 73.2%, above the median of its sector (69.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Nexxir
Companies in the same business, of comparable size and area, outside its group.
- Assurafin Other information service activities Boom · balance sheet 172,598 €
- Chamaeleo Pharma Manufacture of pharmaceutical preparations Merelbeke-Melle · balance sheet 172,711 €
- Property Patrimonium Buying and selling of own real estate Meise · balance sheet 172,739 €
- OLI Invest Buying and selling of own real estate Grimbergen · balance sheet 172,475 €
- Dr H.A. Liège · balance sheet 172,621 €
- Marconiere Saint-Gilles · balance sheet 172,787 €
Frequently asked questions about Nexxir
What is the revenue of Nexxir?
Nexxir files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nexxir?
In Belgium, the VAT number is the company number prefixed with BE: BE1008091207 for Nexxir, if the company is VAT-registered. Its company number (CBE) is 1008.091.207.
Where is the registered office of Nexxir?
According to the CBE register, the registered office of Nexxir is in 1090 Jette.
What is the equity of Nexxir?
At the close of the 2025 financial year, the equity of Nexxir amounts to 126,440 €, a solvency of 73.2% of total assets.
Who manages Nexxir?
The register lists 1 active mandates at Nexxir. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nexxir
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →